EUVIMEDEUVIMED entdecken
Crossref

Antioxidant, pharmacokinetics, ADMET and in silico docking of lead compounds from Leea compactiflora seed extract targeted neuroreceptors

Parthasarathy Sudharsan, Giridharan Bupesh, Longnyu M Konyak, Nokenketla Jamir, Sidhartha Saikia, Jogeswar Panigrahi

BIOCHEMICAL AND CELLULAR ARCHIVES · 03.04.2026 · 26 (1) · 163-175

DOI: 10.51470/bca.2026.26.1.163 ↗

Kurz gefasst

Fachartikel in der Zeitschrift BIOCHEMICAL AND CELLULAR ARCHIVES, online erschienen am 10.04.2026. Verfasst von Parthasarathy Sudharsan und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurodegenerative disorders are characterised by progressive damage of neuron cells with oxidative cell damage and ROS. The bioactive compounds extracted from Leea compactiflora is has high phytochemical composition and therapeutic potential. This present study was aimed to identify the neuroprotective compounds present in Leea compactiflora extract using GC-MS, drug-likeness, ADMET characteristics and molecular docking. The Antioxidant potential was confirmed by using DPPH, ABTS, H2O2 and ABTS assays while comparing standards. The GC-MS result shows a huge amount of bioactive chemicals, which are responsible for neuroprotection, such as compounds like 2,3-Dimethoxyphenol and 5-Cholestene-3-ol, 24-methyl. ADME analysis showed good drug-likeness properties for many compounds and Lipinski’s rule, suggesting good pharmacokinetic properties. Pharmacokinetic analysis also demonstrated the strong potential on blood–brain barrier permeability, central nervous system and high neuroprotective effects. Molecular docking analysis was performed on 5 neuroreceptors and 4 bioactive compounds having a high possibility of neuroprotection. The compounds show high binding affinities to the active sites of the receptors via hydrogen and hydrophobic interactions. The research provides the first detailed analysis of the lead compound composition of Leea compactiflora and its ADME and Parmacokinetic properties. The combined use of GC-MS with in silico pharmacokinetic and docking analysis points to some chemicals from LC having drug-like characteristics and being good starting points for further in vitro and in vivo research.

Zitieren

APA

Sudharsan, P., Bupesh, G., Konyak, L. M., Jamir, N., Saikia, S., & Panigrahi, J. (2026). Antioxidant, pharmacokinetics, ADMET and in silico docking of lead compounds from Leea compactiflora seed extract targeted neuroreceptors. BIOCHEMICAL AND CELLULAR ARCHIVES, 26(1), 163-175. https://doi.org/10.51470/bca.2026.26.1.163

Vancouver

Sudharsan P, Bupesh G, Konyak LM, Jamir N, Saikia S, Panigrahi J. Antioxidant, pharmacokinetics, ADMET and in silico docking of lead compounds from Leea compactiflora seed extract targeted neuroreceptors. BIOCHEMICAL AND CELLULAR ARCHIVES. 2026;26(1):163-175. doi:10.51470/bca.2026.26.1.163

BibTeX
@article{Sudharsan2026,
  author = {Sudharsan, Parthasarathy and Bupesh, Giridharan and Konyak, Longnyu M and Jamir, Nokenketla and Saikia, Sidhartha and Panigrahi, Jogeswar},
  title = {Antioxidant, pharmacokinetics, ADMET and in silico docking of lead compounds from Leea compactiflora seed extract targeted neuroreceptors},
  journal = {BIOCHEMICAL AND CELLULAR ARCHIVES},
  year = {2026},
  volume = {26},
  number = {1},
  pages = {163--175},
  doi = {10.51470/bca.2026.26.1.163}
}
Kostenlos starten →